Burleson & Company, LLC Novartis Ag Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.4 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$853 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$852 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$684 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $247B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...